Joslyn S. Kirby MD, MS, MEd
Professor and Vice Chair of Dermatology, Penn State Health, Hershey, PennsylvaniaDr. Kirby has been is a clinician-researcher in Dermatology for several years. She currently serves as Associate Professor of Dermatology; Director of the Dermatology Residency Program; and Vice Chair of Education. She received her Bachelor’s degree from Virginia Tech. She went on to earn her Medical degree from the University of Virginia School of Medicine. After completing her Dermatology Residency training at the University of Pennsylvania, she joined the faculty at Penn State in Hershey, Pennsylvania. In her clinical and research work, she is interested in acneiform conditions including acne, rosacea, and, especially, hidradenitis suppurativa – its effects on people, outcome measurement, and pathomechanism. She is also interested in value-based research, including alternative payment models. She is the PI of a number of clinical research trials and is an active member of a number of local as well as national committees and organizations.
Disclosures
Dr. Kirby discloses the following:Speaker: AbbVie
Consultant: AbbVie, ChemoCentryx, Incyte, UCB
Advisory Board: AbbVie
Trials with: AbbVie, ChemoCentryx, Incyte, InflaRx, Novartis, UCB
Recent Contributions to PracticeUpdate:
- Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa
- Use of Ultrasound and MRI in the Management of Hidradenitis Suppurativa
- Comorbid Diseases of Hidradenitis Suppurativa
- Information Framing Affects Patients' Decisions About Dysplastic Nevus Management
- Incidence of Long-Term Opioid Use Among Opioid-Naïve Patients With Hidradenitis Suppurativa
- Potential Cost Savings for Topical Steroids
- Laboratory Monitoring During Isotretinoin Therapy for Acne